FDA publishes continuous manufacturing guidance

FDA released draft guidance Tuesday to facilitate the adoption of continuous manufacturing (CM) and help early adopters navigate the application review process for drugs produced with continuous manufacturing methods.

Compared with traditional, step-wise manufacturing processes, continuous manufacturing

Read the full 367 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE